These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 3428676
21. Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study. Broström O, Löfberg R, Ost A, Reichard H. Gut; 1986 Dec; 27(12):1408-13. PubMed ID: 3804019 [Abstract] [Full Text] [Related]
22. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy. Ten Hove JR, Mooiweer E, van der Meulen de Jong AE, Dekker E, Ponsioen CY, Siersema PD, Oldenburg B. Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611 [Abstract] [Full Text] [Related]
23. Colorectal cancer surveillance in patients with ulcerative colitis. Jonsson B, Ahsgren L, Andersson LO, Stenling R, Rutegård J. Br J Surg; 1994 May; 81(5):689-91. PubMed ID: 8044548 [Abstract] [Full Text] [Related]
24. Endoscopic resection is feasible for high-grade dysplasia in patients with ulcerative colitis. Nishio M, Hirasawa K, Chiba S, Ozeki Y, Sawada A, Ikeda R, Fukuchi T, Kobayashi R, Sato C, Inayama Y, Kunisaki R, Maeda S. Scand J Gastroenterol; 2023 Jan; 58(1):101-106. PubMed ID: 36200368 [Abstract] [Full Text] [Related]
25. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Subramanian V, Ramappa V, Telakis E, Mannath J, Jawhari AU, Hawkey CJ, Ragunath K. Inflamm Bowel Dis; 2013 Feb; 19(2):350-5. PubMed ID: 22552948 [Abstract] [Full Text] [Related]
26. Surgical resections of ulcerative colitis associated with dysplasia or carcinoma. Sameshima S, Koketsu S, Takeshita E, Kubota Y, Okuyama T, Saito K, Ueda Y, Sawada T, Oya M. World J Surg Oncol; 2015 Feb 21; 13():70. PubMed ID: 25884202 [Abstract] [Full Text] [Related]
27. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Woolrich AJ, DaSilva MD, Korelitz BI. Gastroenterology; 1992 Aug 21; 103(2):431-8. PubMed ID: 1634062 [Abstract] [Full Text] [Related]
28. High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis. Blonski W, Kundu R, Furth EF, Lewis J, Aberra F, Lichtenstein GR. Scand J Gastroenterol; 2008 Aug 21; 43(7):817-20. PubMed ID: 18584520 [Abstract] [Full Text] [Related]
29. Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis. Korelitz BI, Sultan K, Kothari M, Arapos L, Schneider J, Panagopoulos G. World J Gastroenterol; 2014 May 07; 20(17):4980-6. PubMed ID: 24803809 [Abstract] [Full Text] [Related]
31. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Befrits R, Ljung T, Jaramillo E, Rubio C. Dis Colon Rectum; 2002 May 07; 45(5):615-20. PubMed ID: 12004210 [Abstract] [Full Text] [Related]
32. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia]. Raithel M, Weidenhiller M, Schwab D, Müller S, Hahn EG. Z Gastroenterol; 2001 Oct 07; 39(10):861-75. PubMed ID: 11605156 [Abstract] [Full Text] [Related]
33. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia. Gui X, Liu S, Yan Y, Gao Z. World J Gastroenterol; 2013 Jul 28; 19(28):4504-10. PubMed ID: 23901225 [Abstract] [Full Text] [Related]
34. The fate of low grade dysplasia in ulcerative colitis. Ullman TA, Loftus EV, Kakar S, Burgart LJ, Sandborn WJ, Tremaine WJ. Am J Gastroenterol; 2002 Apr 28; 97(4):922-7. PubMed ID: 12008669 [Abstract] [Full Text] [Related]
35. Ulcerative colitis and colon cancer: the role of surveillance. Broström O. Ann Med; 1989 Aug 28; 21(4):309-11. PubMed ID: 2506915 [Abstract] [Full Text] [Related]
36. Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement. Sugimoto S, Naganuma M, Iwao Y, Matsuoka K, Shimoda M, Mikami S, Mizuno S, Nakazato Y, Nanki K, Inoue N, Ogata H, Kanai T. Gastrointest Endosc; 2017 Mar 28; 85(3):639-646.e2. PubMed ID: 27884517 [Abstract] [Full Text] [Related]
37. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Leidenius M, Kellokumpu I, Husa A, Riihelä M, Sipponen P. Gut; 1991 Dec 28; 32(12):1521-5. PubMed ID: 1773959 [Abstract] [Full Text] [Related]
39. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease. Krugliak Cleveland N, Huo D, Sadiq F, Sofia MA, Marks J, Cohen RD, Hanauer SB, Turner J, Hart J, Rubin DT. Gastrointest Endosc; 2018 May 28; 87(5):1304-1309. PubMed ID: 29307473 [Abstract] [Full Text] [Related]
40. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer. Malecka-Panas E, Kordek R, Biernat W, Tureaud J, Liberski PP, Majumdar AP. Hepatogastroenterology; 1997 May 28; 44(14):435-40. PubMed ID: 9164515 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]